日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ATF7IP inhibits Sorafenib-induced ferroptosis in hepatocellular carcinoma cells by inhibiting CYB5R2 transcription and stabilizing PARK7 protein.

ATF7IP 通过抑制 CYB5R2 转录和稳定 PARK7 蛋白来抑制索拉非尼诱导的肝细胞癌细胞铁死亡

Su Yijie, Huang Sirui, Duan Yang, Zhang Liang, Feng Shengyun, Lv Yingge, Lan Bei, Xuan Chenghao

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity.

USP22 通过其去泛素化酶活性促进肝细胞癌细胞的增殖和索拉非尼耐药性

Wang Xiaochen, Su Yijie, Lan Bei, Li Xuanyuan, Zhang Bodi, Zhang Liang, Wang Yingmei, Zhang Chunze, Xuan Chenghao

Erratum: A CRISPR/Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells

更正:CRISPR/Cas9文库筛选发现CARM1是肝细胞癌细胞铁死亡的关键抑制因子。

Cheng, Yiming; Wang, Xiaochen; Huang, Shuyu; Zhang, Liang; Lan, Bei; Li, Xuanyuan; Chen, Hao; Liu, Zhenfeng; Su, Yijie; Xi, Lishan; Feng, Shengyun; Guo, Yanxuan; Zhou, Jun; Wang, Yingmei; Xuan, Chenghao